
蘇純立
教授
信 箱:chunlisu@ntnu.edu.tw
電 話:(02)7749-1436
聯絡地址:公館校區科教大樓8樓SE808
研究專長:天然物之抗腫瘤機轉、營養基因體學、營養遺傳學、訊息傳遞、細胞與分子生物學、免疫學
授課領域:營養學、生物化學、實驗性研究、基礎醫學、生物技術
配對植化素及腫瘤分子變異於精準營養
腫瘤進展(tumor progression)與多重基因異常有關,癌症精準醫療(precision medicine in oncology)是根據病人腫瘤的基因特徵,將癌症精準分群,精準選擇用藥。本研究分析多種基因資料庫,發現抑癌基因TP53突變(增加cisplatin藥物阻抗)是膀胱泌尿上皮癌最常見的基因變異,且致癌基因HRAS有較高的突變率與mRNA表現,也發現植化素紫檀茋(pterostilbene)可逆轉cisplatin的藥物阻抗,尤其是HRAS突變/高表現且TP53突變的膀胱癌細胞,其機制與致癌蛋白RAS訊息傳遞、細胞自噬(autophagy)與細胞衰老(cell senescence)有關。實驗使用HRAS與TP53皆突變的膀胱癌T24細胞以及HRAS與TP53皆正常的E7細胞,證實紫檀茋明顯增加T24細胞之細胞自噬與細胞衰老,且在動物實驗可增加臨床一線用藥cisplatin合併gemcitabine的效用。這些結果指出植化素紫檀茋可應用於治療具致癌性HRAS及cisplatin阻抗的膀胱癌 [1]。我們的研究利用基因表現資料庫的大數據分析,針對癌細胞的各別基因變異,相對應找出存在於食物及中草藥的配對天然化合物,增加癌症治療效果。
參考文獻
[1] Chen, Y. T., Huang, Z. Y., Tang, H. H., Kuo, W. T., Wu, S. Y., Lan, S. H., Chang, K. H., Lin, P. L., Lee, M. F., Cheng, H. C., Liu, H. S., Huang, C. F., Huang, G. C. & Su, C. L. (2020) Pterostilbene sensitizes cisplatin-resistant human bladder cancer cells with oncogenic HRAS, Cancers (Basel). 12, 2869
Chun-Li Su’s research interests have centered around the anti-cancer mechanisms of naturally occurring components derived from culinary herbs and spices. Using transcriptomic data and novel gene screening platforms, she not only determined that polyphenol curcumin enhances chemosensitivity [1] by repressing a novel target of oncogenic Aurora-A [2] and suppresses a transcription factor NF-ĸB by inhibiting CD4-T-cell-receptor-signaling [3], but also revealed that a novel arylnaphthalide lignan justicidin A acts as an autophagy inducer [4] and inflammation suppressor [5]. In precision nutrition, polyphenol phytoalexin pterostilbene was discovered to preferentially sensitize cisplatin-resistant bladder cancer with undruggable oncogenic HRAS [6], a novel diosgenin saponin formosanin C was demonstrated to be a potent ferroptosis inducer against hepatocellular carcinoma with a higher NCOA4 expression via ferritinophagy [7], and co-administrating curcumin with anti-cancer drugs was revealed to utilize the synthetic lethal pair to concurrently suppress Aurora-A and induce autophagy for early stage bladder cancer with high expression of Aurora-A [8]. By conducting an integrated analysis of differentially expressed genes and pathways using a database of patients, ferroptosis was identified as a targetable metabolic niche in triple-negative breast cancer, and triple-negative breast cancer was shown to be vulnerable to formosanin C-induced ferroptosis [9]. Nevertheless, antipsychotic thioridazine [10] and antibiotic antimycin A [11] were successfully repurposed to overcome the drug resistance of cancer stem cells in glioblastoma and non-small cell lung cancer, respectively. More recently, using in silico analysis and biochemical validations, an herbal medicine Virofree was found to target viral entry and replication of SARS-CoV-2, especially against Delta and Omicron variants, and to prevent ferroptosis, cytokine storm, acute respiratory distress syndrome, and pulmonary fibrosis, alleviating complications of COVID-19 [12]. Quantitative proteomics and gene ontology enrichment analysis were performed, which revealed that suboptimal folic acid exposure rewired oncogenic metabolism and proteomics signatures to promote breast cancer progression [13]. These findings opened new avenues of research in nutritional biochemistry, and the novel gene expression screening platforms provided a short-cut to successfully predict possible mechanisms of culinary herbs and spices, and to identify strategies capable of overcoming drug resistance by shedding light on the interrelationships among small molecules, genes, and disease in precision nutrition.
References
1. Ke, C. S., Liu, H. S., Yen, C. H., Huang, G. C., Cheng, H. C., Huang, C. Y. & Su, C. L. (2014) Curcumin-induced Aurora-A suppression not only causes mitotic defect and cell cycle arrest but also alters chemosensitivity to anticancer drugs, The Journal of nutritional biochemistry. 25, 526-39.
2. Liu, H. S., Ke, C. S., Cheng, H. C., Huang, C. Y. & Su, C. L. (2011) Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells occurs partly through inhibition of Aurora A, Mol Pharmacol. 80, 638-46.
3. Liao, S. C., Hsu, H. W., Chuang, K. L., Huang, Z. Y., Lin, K. T., Hsu, W. H., Chang, K. H., Huang, C. F. & Su, C. L. (2019) Using the Pleiotropic Characteristics of Curcumin to Validate the Potential Application of a Novel Gene Expression Screening Platform, Nutrients. 11, 1397.
4. Won, S.-J., Wu, H.-C., Lin, K.-T., Yu, C.-H., Chen, Y.-T., Wu, C.-S., Huang, C.-Y. F., Liu, H.-S., Lin, C.-N. & Su, C.-L. (2015) Discovery of molecular mechanisms of lignan justicidin A using L1000 gene expression profiles and the Library of Integrated Network-based Cellular Signatures database, Journal of Funct Foods. 16, 81-93.
5. Won, S.-J., Yen, C.-H., Hsieh, H.-W., Chang, S.-W., Lin, C.-N., Huang, C.-Y. F. & Su, C.-L. (2017) Using connectivity map to identify natural lignan justicidin A as a NF-kappaB suppressor, Journal of Funct Foods. 34, 68-76.
6. Chen, Y. T., Huang, Z. Y., Tang, H. H., Kuo, W. T., Wu, S. Y., Lan, S. H., Chang, K. H., Lin, P. L., Lee, M. F., Cheng, H. C., Liu, H. S., Huang, C. F., Huang, G. C. & Su, C. L. (2020) Pterostilbene sensitizes cisplatin-resistant human bladder cancer cells with oncogenic HRAS, Cancers (Basel). 12, 2869.
7. Lin, P. L., Tang, H. H., Wu, S. Y., Shaw, N. S. & Su, C. L. (2020) Saponin Formosanin C-induced Ferritinophagy and Ferroptosis in Human Hepatocellular Carcinoma Cells, Antioxidants (Basel). 9, 682.
8. Fan, Y. W., Lu, I. C., Hsu, M. Y., Kuo, W. T., Wu, S. Y., Lan, S. H., Wang, P. Y., Chen, C. Y., Liu, H. S. & Su, C. L. (2023) Synthetic lethality in human bladder cancer cells by curcumin via concurrent Aurora A inhibition and autophagy induction, J Nutr Biochem. 121, 109438.
9. Chen, H. C., Tang, H. H., Hsu, W. H., Wu, S. Y., Cheng, W. H., Wang, B. Y. & Su, C. L. (2022) Vulnerability of triple-negative breast cancer to saponin formosanin C-induced ferroptosis, Antioxidants (Basel). 11, 298.
10. Cheng, H. W., Liang, Y. H., Kuo, Y. L., Chuu, C. P., Lin, C. Y., Lee, M. H., Wu, A. T., Yeh, C. T., Chen, E. I., Whang-Peng, J., Su, C. L. & Huang, C. Y. (2015) Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data, Cell Death Dis. 6, e1753.
11. Yeh, C. T., Su, C. L., Huang, C. Y., Lin, J. K., Lee, W. H., Chang, P. M., Kuo, Y. L., Liu, Y. W., Wang, L. S., Wu, C. H., Shieh, Y. S., Jan, Y. H., Chuang, Y. J., Hsiao, M. & Wu, A. T. (2013) A preclinical evaluation of antimycin a as a potential antilung cancer stem cell agent, Evid Based Complement Alternat Med. 2013, 910451.
12. Doan, L. H., Chu, L. W., Huang, Z. Y., Nguyen, A. T., Lee, C. Y., Huang, C. L., Chang, Y. F., Hsieh, W. Y., Nguyen, T. T. H., Lin, C. H., Su, C. L., Chuang, T. H., Lai, J. M., Wang, F. S., Yang, C. J., Liu, H. K., Ping, Y. H. & Huang, C. F. (2022) Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2, Front Pharmacol. 13, 905197.
13. Huang, A., Huang, S. Y., Shah, P., Ku, W. C., Huang, K. T., Liu, Y. F., Su, C. L. & Huang, R. S. (2022) Suboptimal folic acid exposure rewires oncogenic metabolism and proteomics signatures to mediate human breast cancer malignancy, J Nutr Biochem. 106, 109000.
國家 | 學校名稱 | 系所 | 學位 | 期間 |
---|---|---|---|---|
美國 | 康乃爾大學 | 營養學系 | 博士 | 1991.08 ~ 1995.08 |
美國 | 康乃爾大學 | 營養學系 | 碩士 | 1989.08 ~ 1991.07 |
台灣 | 台北醫學院 | 保健營養學系 | 學士 | 1984.08 ~ 1988.06 |
服務機關名稱 | 單位 | 職務 |
---|---|---|
長榮大學 | 護理學系 | 教授 |
長榮大學 | 呼吸照護技術學系 | 系主任 |
長榮大學 | 護理學系 | 副教授 |
美國國家衛生研究院(NIH) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Laboratory of Cellular and Developmental Biology (LCDB) | 訪問學者 |
長榮大學 | 醫務管理學系 | 副教授 |
長榮大學 | 教務處學術研究組(研究發展處前身) | 組長 |
美國康乃爾大學 | Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine; Department of Biomedical Sciences, College of Veterinary Medicine | 訪問學者 |
Life (SCI; Impact factor: 3.8) | Special issue「Tumor Progression, Microenvironments, and Therapeutics」 | Guest Editor |
國際學術組織 | 「亞太腫瘤暨慢性病營養學會(Asia Pacific Nutrition Society for Oncology and Chronic Diseases,APNOC)」 | 理事及召集人(會員推廣委員會) |
衛生福利部國民健康署 | 研修訂國人膳食營養基準 | 核閱委員 |
考選部 | 國家考試 | 典試委員 |
科技部 | 專題研究計畫 | 複審委員 |
Nutrients (SCI; Impact factor: 6.7) | Guest Editor Committee | Member |
Frontiers in Pharmacology (SCI; Impact factor: 6.0) | Special issue「Ethnopharmacology」 | Review Editor |
衛生福利部國民健康署 | 參考國際營養風險篩檢工具,發展本土社區營養風險篩檢工具 | 專家諮詢委員 |
大學校院 | 系所評鑑 | 自我評鑑委員 |
Annual Conference of American Society for Nutrition | Poster Competition | Judge |
Annual Conference of the Nutrition Society of Taiwan | Oral Competition | Judge |
國立台灣師範大學 | 人類發展與家庭學系, 營養科學與教育組(學籍分組) | 召集人 |
長榮大學 | 校教師評審委員會、校務會議、院教師評審委員會、院教師評鑑小組、院務會議、生物實驗安全委員會、動物實驗管理小組、基因重組實驗安全委員會、教學獎勵及補助評選小組、學術研究及創作獎(補)助審查委員會、校務發展委員會、經費稽核委員會、獎助學金暨工讀金審查委員會、學生申訴評議委員會、衛生委員會、膳食督導委員會(召集人)、校園規劃委員會、招生委員會 | 委員 |
類別 | 獎項名稱 | 頒獎單位 |
---|---|---|
教師榮譽 | 服務績優獎 | 長榮大學 |
教師榮譽 | 學術研究成果獎勵 | 長榮大學 |
教師榮譽 | 學術績優獎 | 長榮大學 |
教師榮譽 | 績優教師 | 長榮大學 |
教師榮譽 | 績優導師 | 長榮大學 |
教師榮譽 | 資深優良教師 | 教育部 |
教師榮譽 | 三等服務獎章 | 行政院 |
教師榮譽 | 教學優良獎 | 國立台灣師範大學 |
教師榮譽 | 獎勵特殊優秀人才 | 國科會, 科技部 |
教師榮譽 | Visiting Fellowship by the National Institutes of Health (NIH) visiting program | 美國國家衛生研究院 |
教師榮譽 | President Award for outstanding performance to the field of nutrigenomics and nutrigenetics | Asia Pacific Nutrigenomics Nutrigenetics Organization |